April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Abstract WMS 2019
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Poster WMS 2019
A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s Disease leveraging the voice of the patient – Sakshi Sardar, et al. Abstract # 1314
Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease – Derek Hill, et al. Abstract # 1289
Identifying and Controlling Variability in Digital Health Measures in Parkinson’s Disease Clinical Trials – George Roussos, et al. Abstract # 342
Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium – Martijn Müller, et al. Abstract # 341
The Development of a Parkinson’s Disease Biomarker Inventory Dashboard – Michael Pauley, et al. Abstract # 308
Model Innovation in Parkinson’s Disease Drug Development: Linking Quantitative Systems Pharmacology to the Patient Voice – Jeff Barrett, et al. Abstract # 287
Considerations for Participation in PPP Projects: Learnings from the Critical Path for Parkinson’s Consortium, D. Stephenson Session: # S0802-L, Understanding of Different Set Ups of PPP, Benefits of PPPs and Learnings of Recent Projects to Facilitate
November 13, 2020 C-Path’s PKDOC Presentation on Fluid-Based Biomarkers Critical Path Institute’s John-Michael Sauer, Ph.D. presents information on fluid-based biomarkers and how they can be applied